Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

PROCF

Sofgen Pharma S.A.

USD

Set alert

Price alert · PROCF

All alert types
0.03 USD 0.00 0.00%
As of Oct 29, 2026
0.0251 Day range 0.0251
0.0001 52-week range 1.40
YTD
-0.40%
1 year
-98.21%
Open
0.0251
Prev close
0.025
Mkt cap
58.18M
Vol
17
Avg vol
5.01K
EPS
-0.68
P/E
0.00
More statistics
Low
0.0251
High
0.0251

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for PROCF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

0.12 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 10.7×
FY 2021: -8.9×FY 2022: 14.6×FY 2023: 10.7×
FY 2021 5y median 10.7× FY 2023
P/S 1.0×
FY 2021: 2.4×FY 2022: 1.3×FY 2023: 1.0×
FY 2021 5y median 1.3× FY 2023
P/B 2061×
FY 2021: -13.9×FY 2022: -14.7×FY 2023: 2061×
FY 2021 5y median -13.9× FY 2023
P/FCF 5.8×
FY 2021: 99.5×FY 2022: -28.6×FY 2023: 5.8×
FY 2021 5y median 5.8× FY 2023
EV/EBITDA 6.8×
FY 2021: 168×FY 2022: 8.6×FY 2023: 6.8×
FY 2021 5y median 8.6× FY 2023
EV/Sales 1.7×
FY 2021: 2.8×FY 2022: 1.9×FY 2023: 1.7×
FY 2021 5y median 1.9× FY 2023
FCF Yield 17.3%
FY 2021: 1.0%FY 2022: -3.5%FY 2023: 17.3%
FY 2021 5y median 1.0% FY 2023

Profitability

Gross Margin 56.2%
FY 2021: 57.0%FY 2022: 58.3%FY 2023: 56.2%
FY 2021 5y median 57.0% FY 2023
Operating Margin 17.0%
FY 2021: -3.7%FY 2022: 2.4%FY 2023: 17.0%
FY 2021 5y median 2.4% FY 2023
Net Margin 9.5%
FY 2021: -26.5%FY 2022: 9.0%FY 2023: 9.5%
FY 2021 5y median 9.0% FY 2023
ROE 19211.0%
FY 2021: 155.0%FY 2022: -99.8%FY 2023: 19211.0%
FY 2021 5y median 155.0% FY 2023
ROIC 18.7%
FY 2021: -4.7%FY 2022: 2.4%FY 2023: 18.7%
FY 2021 5y median 2.4% FY 2023
ROA 8.5%
FY 2021: -23.8%FY 2022: 8.2%FY 2023: 8.5%
FY 2021 5y median 8.2% FY 2023

Growth (YoY)

Revenue 5.1%
FY 2021: 0.0%FY 2022: -0.1%FY 2023: 5.1%
FY 2021 FY 2023
Operating Income 634.6%
FY 2021: 0.0%FY 2022: 165.2%FY 2023: 634.6%
FY 2021 FY 2023
EPS (diluted) 11.1%
FY 2021: 0.0%FY 2022: 133.0%FY 2023: 11.1%
FY 2021 FY 2023
Free Cash Flow 503.0%
FY 2021: 0.0%FY 2022: -293.2%FY 2023: 503.0%
FY 2021 FY 2023

Financial Health

Current Ratio 0.7×
FY 2021: 0.8×FY 2022: 0.7×FY 2023: 0.7×
FY 2021 5y median 0.7× FY 2023
Quick Ratio 0.4×
FY 2021: 0.6×FY 2022: 0.5×FY 2023: 0.4×
FY 2021 5y median 0.5× FY 2023
Debt / Equity 1426×
FY 2021: -3.7×FY 2022: -7.9×FY 2023: 1426×
FY 2021 5y median -3.7× FY 2023
Net Debt / EBITDA 2.7×
FY 2021: 26.7×FY 2022: 2.7×FY 2023: 2.7×
FY 2021 5y median 2.7× FY 2023
Interest Coverage 1.8×
FY 2021: -0.2×FY 2022: 0.4×FY 2023: 1.8×
FY 2021 5y median 0.4× FY 2023

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2021 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2021 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31